Skip to main content

This website uses cookies. By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies.

I agree

Main navigation (without target group)

  • About Sobi
    • Who We Are
    • Leadership
    • Rare Diseases
    • Responsibility
  • Countries and Products
    • United States
    • Canada
  • Investigator Sponsored Studies
    • Transparency and Integrity
    • Submission Requirements
    • Review Process
    • Areas of Interest
  • News
  • Careers
  • Contact Us

Breadcrumb

  1. Home
  2. News

News archive

A news archive from Sobi in North America

Health Canada validates Orfadin® capsule filing

07/14/2016 - 06:54

Orfadin® 20 mg capsule approved in the US

06/15/2016 - 06:55

Orfadin® Oral Suspension approved in the US

04/26/2016 - 06:56
  • Load More
Smiling woman

Global News

Sobi publishes the report for the fourth quarter and full-year 2018

More Global News

Filter by Year

2019
2018
2017
2016
2015
2014

News archive

A news archive from Sobi in North America

Health Canada validates Orfadin® capsule filing

07/14/2016 - 06:54

Orfadin® 20 mg capsule approved in the US

06/15/2016 - 06:55

Orfadin® Oral Suspension approved in the US

04/26/2016 - 06:56
  • Load More
Smiling woman

Global News

Sobi publishes the report for the fourth quarter and full-year 2018

More Global News

Filter by Year

2019
2018
2017
2016
2015
2014

Footer Menu

  • Cookies
  • Terms of use

Copyright Notice:  © Sobi, Inc. 2018

This site contains medical information that is intended for residents of the United States and Canada only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy 

Sobi United States
+1 781-786-7370
890 Winter Street
Waltham, MA 02451, USA

Sobi Canada
+1 289-291-3852
1155 North Service Rd. West, Unit #11,
Oakville, Ontario, Canada L6M 3E3